Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Protalix Biotherapeutics Inc. buy marge

Protalix Biotherapeutics Inc.
Start price
€10.35
12.04.17 / 50%
Target price
€20.00
26.07.17
Performance (%)
-40.29%
End price
€6.18
26.07.17
Summary
This prediction ended on 26.07.17 with a price of €6.18. Massive losses of -40.29% were the result for the BUY prediction by marge. marge has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Protalix Biotherapeutics Inc. 2.013% 2.013% -9.362% 34.335%
iShares Core DAX® 0.224% 2.457% 21.634% 71.886%
iShares Nasdaq 100 0.371% -0.320% 5.422% 113.046%
iShares Nikkei 225® 0.972% -0.829% 15.333% 47.267%
iShares S&P 500 0.417% -0.157% 3.125% 68.687%

Comments by marge for this prediction

In the thread Protalix Biotherapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -40.29%
Target price 2.000
Change
Ends at 26.07.17

marge stimmt der Buy-Einschätzung von datca zu

marge stimmt am 124.2017 der Buy-Einschätzung von datca mit dem Kursziel 2€ zu.
Überschrift: Protalix for the Treatment of Cystic Fibrosis and Fabry Disease

marge 
0
Report Share
12.04.17
Prediction Buy
Perf. (%) -40.29%
Target price 2.000
Change
Ends at 26.07.17

(Vom Mitglied beendet)

marge 
0
Report Share
26.07.17